Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 2, 2019
Reporting Period: The filing reports on events occurring on October 1, 2019, specifically regarding an investor presentation for a securities offering.
Key Financial Metrics
This filing is a disclosure of a regulatory event and does not contain audited financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics. The filing text does not provide a clear value for any specific financial performance indicator.
Material Changes
The primary material event disclosed is the filing of an investor presentation dated October 1, 2019. This presentation was made available to investors during the offering process for shares of the Company's 8% Series A Cumulative Convertible Preferred Stock. The presentation is incorporated by reference as Exhibit 99.1.
Guidance, Outlook, and Risks
Offering Details: The Company is conducting an offering of 8% Series A Cumulative Convertible Preferred Stock under a Registration Statement on Form S-3 (Registration No. 333-228773).
Regulatory Status: The information contained in the investor presentation is not deemed filed for purposes of Section 18 of the Securities Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Emerging Growth Company: The registrant has indicated it is an emerging growth company.
Investor Verification Checklist
- Verify the terms and conditions of the 8% Series A Cumulative Convertible Preferred Stock offering.
- Review the full text of the Investor Presentation (Exhibit 99.1) for specific financial projections or operational updates not included in this summary.
- Confirm the status of the Registration Statement on Form S-3 (No. 333-228773).
- Check subsequent filings for the final results of the preferred stock offering.